NIH awards $28.6M for R&D in Physical, Engineering, and Life Sciences to Experimental Pathology Laboratories
Contract Overview
Contract Amount: $28,584,735 ($28.6M)
Contractor: Experimental Pathology Laboratories, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2000-06-15
End Date: 2008-09-29
Contract Duration: 3,028 days
Daily Burn Rate: $9.4K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: R&D-OTHER R & D-B RES
Place of Performance
Location: HERNDON, FAIRFAX County, VIRGINIA, 20172
State: Virginia Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $28.6 million to EXPERIMENTAL PATHOLOGY LABORATORIES, INC. for work described as: R&D-OTHER R & D-B RES Key points: 1. The contract value of $28.6 million over 8 years indicates a significant investment in research and development. 2. Full and open competition was utilized, suggesting a competitive bidding process. 3. The contract type (Cost Plus Fixed Fee) carries inherent risk for the government in terms of cost overruns. 4. The sector is Research and Development, a critical area for scientific advancement.
Value Assessment
Rating: fair
The contract was awarded under a Cost Plus Fixed Fee structure, which can lead to higher costs for the government compared to fixed-price contracts. The final award amount of $28.6 million needs to be assessed against the scope of work and deliverables to determine true value.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, which typically fosters price discovery and competitive pricing. However, the Cost Plus Fixed Fee structure may mitigate some of the cost savings expected from competition.
Taxpayer Impact: The use of full and open competition is generally beneficial for taxpayers by promoting market efficiency. However, the cost-plus nature of the contract warrants careful monitoring to ensure costs remain reasonable.
Public Impact
This contract supports critical research and development activities within the physical, engineering, and life sciences. The long duration of the contract (over 8 years) suggests a sustained need for the services provided. The award to a single entity, Experimental Pathology Laboratories, Inc., highlights the specialized nature of the research.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Cost Plus Fixed Fee contract type can lead to cost overruns.
- Long contract duration may not adapt well to evolving research needs.
- Lack of specific performance metrics makes value assessment difficult.
Positive Signals
- Full and open competition utilized.
- Supports critical R&D in vital scientific fields.
- Long-term commitment to research.
Sector Analysis
This contract falls within the Research and Development sector, specifically focusing on physical, engineering, and life sciences. Spending in this sector is crucial for innovation and national competitiveness, with benchmarks varying widely based on the specific research area and agency.
Small Business Impact
The data indicates this contract was not awarded to a small business. Further analysis would be needed to determine if small business participation was sought or achieved through subcontracting.
Oversight & Accountability
The long duration and cost-plus nature of this contract necessitate robust oversight from the Department of Health and Human Services to ensure funds are used efficiently and effectively towards research objectives.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Cost Overruns Risk (CPFF)
- Scope Creep Risk
- Lack of Measurable Outcomes
- Long Contract Duration Inflexibility
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, va, dca, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $28.6 million to EXPERIMENTAL PATHOLOGY LABORATORIES, INC.. R&D-OTHER R & D-B RES
Who is the contractor on this award?
The obligated recipient is EXPERIMENTAL PATHOLOGY LABORATORIES, INC..
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $28.6 million.
What is the period of performance?
Start: 2000-06-15. End: 2008-09-29.
What specific research outcomes were achieved with the $28.6 million awarded?
The provided data does not detail the specific research outcomes or deliverables associated with this contract. To assess the true value, a review of progress reports, final research findings, and any publications or patents resulting from the funding would be necessary. Understanding the tangible scientific advancements is key to evaluating the return on investment.
How were cost controls managed under the Cost Plus Fixed Fee structure to mitigate government risk?
The Cost Plus Fixed Fee (CPFF) structure inherently shifts some cost risk to the government. Effective oversight would involve rigorous auditing of direct costs, clear definition of indirect cost pools, and strict adherence to the negotiated fixed fee. Regular reviews and milestone tracking are crucial to ensure the contractor remains within projected cost parameters and the fee is justified by performance.
Was the full and open competition process effective in securing competitive pricing for the specialized R&D services?
While full and open competition was used, the CPFF contract type can complicate direct price comparisons. The effectiveness would depend on the number and quality of bids received, the government's negotiation strategy, and whether the final negotiated cost represented a fair market value for the specialized R&D. Benchmarking against similar contracts for comparable services would provide further insight.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › OTHER RESEARCH/DEVELOPMENT
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Offers Received: 1
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Address: 22866 SHAW RD, STERLING, VA, 10
Business Categories: Category Business, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $110,796,035
Exercised Options: $76,938,023
Current Obligation: $28,584,735
Contract Characteristics
Multi-Year Contract: Yes
Timeline
Start Date: 2000-06-15
Current End Date: 2008-09-29
Potential End Date: 2008-09-29 00:00:00
Last Modified: 2011-08-08
More Contracts from Experimental Pathology Laboratories, Inc.
- Management and Support of the Niehs Archives, Frozen Tissue Bank and Specimen Repository — $41.6M (Department of Health and Human Services)
- "pathology Peer Review and Pathology Support for the Dntp and DIR AT Niehs" Experimental Pathology Laboratories (EPL) — $34.0M (Department of Health and Human Services)
- Pathology Support for the NTP QA — $32.3M (Department of Health and Human Services)
- Management and Support of an Archives and Repository Contract (aarc) for the National Toxicology Program (NTP) and the National Institute of Environmental Health Sciences (niehs) — $28.4M (Department of Health and Human Services)
- Management and Support of an Archives and Repository Contract for the National Toxicology Program (NTP) and the National Institute of Environmental Health Sciences (niehs) Divisions of Translational Toxicology (DTT) and Intramural Research (DIR) — $13.7M (Department of Health and Human Services)
View all Experimental Pathology Laboratories, Inc. federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →